If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Thursday, December 13, 2018 
Market Status: CLOSE
About us and Governance Investor Relations Contact
Advanced search

Market News


ROPHARMA SA - RPH

EGSM resolutions 16.03.2018

Release Date: 3/16/2018 6:30:09 PM

IRIS Code: 69C49

Current report persuant to Regulation no. 1/2006 of CNVM

Report date: 16.03.2018

Name of the issuing company: Ropharma SA

Headquarters: Brasov, 55 Iuliu Maniu St, Brasov

Sole Registration Code: 1962437

Registration number in the Companies’ Register: J8/2886/2007

Subscribed and paid capital: 51.126.741,3 lei

Regulated market: BVB, Standard Category

 

Important event to be reported

ROPHARMA S.A. informs the investors that on March 16, 2018, 11.00 a.m., the Extraordinary General Meeting of the Shareholders took place and decided as follows:

1.      Unanimously approves for Ropharma S.A. as a borrower, co-debtor or guarantor with Teo Health S.A., Ropharma Logistic S.A. and Aesculap Prod SRL, to contract investment loans with a total amount of maximum EUR 13.777 million for refinancing existing term loans, as well as for financing the construction works and the acquisition of equipment necessary for the development of a hospital unit.

2.      Unanimously approves for Ropharma S.A. as a borrower, co-debtor or guarantor with Teo Health S.A., Ropharma Logistic S.A. and Aesculap Prod SRL, to contract a current loan limit of up to EUR 6.5 million, for the current activity.

3.      Unanimously approves that the loans from the previous paragraphs shall be guaranteed with the already established guarantees, which can be extended, maintained or renewed on the new loans, as well as with other movable or immovable assets belonging to the patrimony of the company, depending on the negotiations with the bank.

4.      Approves with the majority of votes the empowerment of Mr. Alin Constantin Radasanu to sign in the name and on behalf of Ropharma S.A. loan agreements, warranty contracts, subsequent addenda, and all documents necessary or required by the bank to carry out the present mandate.

5.      Unanimously approves the date of April 2nd 2018 as registration date, according to CNVM Regulation no. 6/2009.

6.      Unanimously approves the date of March 30th 2018 as ex-date, according to CNVM Regulation no. 6/2009.

7.      Unanimously approves the empowerment of Mr. Mihai Bratescu, ID BV697915 and Mrs. Bianca Capota, ID BV764250 who shall fulfill the publicity and registration formalities regarding the General Meeting of Shareholder’s Decisions.

 

Dr. pharm. MIHAI MIRON

CEO

 

 



 Print

Information provided by IRIS, the news platform of the Bucharest Stock Exchange.

______________________

Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


©2016 Bucharest Stock Exchange. All rights reserved